
Centogene N.V. CNTG
Annual report 2023
added 12-27-2025
Centogene N.V. Operating Cycle 2011-2026 | CNTG
Annual Operating Cycle Centogene N.V.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 170 | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 170 | 170 | 170 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
161 | $ 119.77 | -0.5 % | $ 36.4 B | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 20.56 | 3.37 % | $ 221 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.57 | -0.34 % | $ 936 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.42 | 2.9 % | $ 1.89 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 24.62 | 1.03 % | $ 684 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 180.56 | 0.7 % | $ 8.95 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
143 | $ 198.14 | -0.2 % | $ 141 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
198 | $ 132.26 | 1.49 % | $ 21 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 29.09 | - | $ 20 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.17 | 0.94 % | $ 489 M | ||
|
Guardant Health
GH
|
128 | $ 84.86 | -1.78 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.93 | 1.74 % | $ 95.1 K | ||
|
Biomerica
BMRA
|
204 | $ 2.11 | 0.48 % | $ 4.85 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 518.54 | -0.28 % | $ 15 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 116.5 | 3.04 % | $ 9.61 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 266.73 | -0.8 % | $ 22.2 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 5.19 | 5.7 % | $ 481 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 83.94 | 1.45 % | $ 5.67 B | ||
|
NeoGenomics
NEO
|
102 | $ 8.68 | 3.95 % | $ 1.11 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.42 | -1.98 % | $ 2.04 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 191.42 | -1.41 % | $ 21.2 B | ||
|
ENDRA Life Sciences
NDRA
|
412 | $ 5.14 | 3.63 % | $ 4.05 M | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.84 | 4.69 % | $ 399 M | ||
|
Natera
NTRA
|
81.5 | $ 207.19 | -3.47 % | $ 20.4 B | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | ||
|
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M |